2017 Congress

BIO US 2017

San Diego, June 2017

THERAVECTYS will join the BIO US 2017 to present its new portfolio strategy and meet with partner to identify out-licensing and co-development opportunities.


2015 Congress

IMVACS 10th annual meeting

Boston, September 2015

Wrapping up its tenth year, ImVacS played host to a record-breaking 320+ professionals working in immunotherapies and vaccines. The 2015 event brought with it a newly added plenary keynote, given by Dr. Polly Matzinger of the NIH, that touched upon everything from adjuvants to tregs while challenging assumptions and encouraging new ways of thinking.

ESGCT Helsinki

Helsinki, September 2015

The ESGCT Annual Meeting provides an opportunity for scientists, clinicians and industry professionals to share new data, learn from peers, and discover global advances within the Gene and Cell Therapy field. With nearly 1000 participants from 40 countries, the ESGCT Annual Meeting is this year organised in collaboration with the Finnish Society of Gene Therapy.

Towards an HIV Cure 2015 / IAS 2015

Vancouver, July 2015

Towards an HIV Cure, an initiative of the International AIDS Society (IAS) provides leadership in facilitating more concerted efforts to accelerate global scientific research towards a cure for HIV and in advocating for increased investment in HIV cure research.

ASGCT 2015

New Orleans, May 2015

The 18th Annual Meeting will bring together 1,700 of the world’s top researchers, clinicians, fellows, and trainees for four days of education, presentations, networking, and social events.

PEGS 2015

Boston, May 2015

The Essential Protein Engineering Summit is the premier event for antibody and protein science research and the biologics industry.

4th Global Forum on Tuberculosis B Vaccines

Shanghai, April 2015

The Essential Protein Engineering Summit is the premier event for antibody and protein science research and the biologics industry.
Poster session.

Bio Europe Spring

Paris, March 2015

The Essential Protein Engineering Summit is the premier event for antibody and protein science research and the biologics industry.
Panel Discussion.

JP Morgan - Bio Showcase

San Francisco, January 2015

Biotech Showcase™ is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences.


2014 Congress

ASH 2014

San Francisco, December 2014

56th ASH Annual Meeting & Exposition: The premier event in malignant & non-malignant hematology

xii international symposium of HTLV

Sao Paulo, December 2014

XII International Symposium of HTLV in Brazil and IV Paulista Symposium of HTLV: featuring the theme HTLV, the meeting will cover different issues and initiatives.

Bio Europe 2014

Frankfurt, November 2014

BIO-Europe® is Europe's largest partnering conference serving the global biotechnology industry.

Cell Culture & Bioprocessing Congress 2014

London, November 2014

3rd Annual Cell Culture & Bioprocessing Congress 2014

US conference on AIDS

San Diego, October 2014

18th annual United States Conference on AIDS (USCA)

Emerging oncogenic viruses

San Pietro, June 2014

OMS/International agency for research on cancer. The objectives of the meeting will be the discussion and critical evaluation of the epidemiology, immunology, and biology of cancer-associated viruses.


Rome, June 2014

From the understanding of biological and molecular bases of the transforming and neuropathogenetic activities of HTLV to the development of novel therapeutic strategies.

International Symposium HIV &
Emerging Infectious Diseases

Marseille, May 2014

ASGCT 2014

Washington, May 2014

BioEquity Europe 2014

Amsterdam, May 2014

Viral Vectors & Vaccines program


Washington, March 2014

Viral Vectors & Vaccines program

Journées Québécoises HIV

Québec, March 2014

Symposiumsida: Viral Vectors & Vaccines program